{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:19:00Z","timestamp":1723162740376},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.encep.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:38:04Z","timestamp":1715085484000},"page":"361-362","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The French National Agency for the Safety of Medicines and Health Products (ANSM) warns doctors about the risks of prescribing valproate to men of reproductive age"],"prefix":"10.1016","volume":"50","author":[{"given":"Guillaume","family":"Fond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tham Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bach","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2024.03.001_bib0045","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1038\/s41598-020-74409-x","article-title":"Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France","volume":"10","author":"Coste","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.encep.2024.03.001_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40264-022-01234-8","article-title":"Compliance with prescribing and dispensing conditions for valproate and related substances in girls and women of childbearing potential: a survey of community pharmacists in France","volume":"46","author":"Fauvelle","year":"2023","journal-title":"Drug Saf"},{"key":"10.1016\/j.encep.2024.03.001_bib0055","doi-asserted-by":"crossref","first-page":"102126","DOI":"10.1016\/j.respe.2023.102126","article-title":"Regulation of medical research in France: striking the balance between requirements and complexity","volume":"71","author":"Boyer","year":"2023","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.encep.2024.03.001_bib0060","doi-asserted-by":"crossref","first-page":"102147","DOI":"10.1016\/j.respe.2023.102147","article-title":"Reducing prescription and addressing benzodiazepine dependence through withdrawal and tapering protocols - forging an alliance between public health actors and clinical practices","volume":"71","author":"Fond","year":"2023","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.encep.2024.03.001_bib0065","unstructured":"ANSM. Valproate et d\u00e9riv\u00e9s\u00a0: risque potentiel de troubles neurod\u00e9veloppementaux chez les enfants dont le p\u00e8re a \u00e9t\u00e9 trait\u00e9 dans les 3 mois qui pr\u00e9c\u00e8dent la conception. ANSM n.d. https:\/\/ansm.sante.fr\/informations-de-securite\/valproate-et-derives-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-dans-les-3-mois-qui-precedent-la-conception. (accessed August 5, 2023)."},{"key":"10.1016\/j.encep.2024.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/epi.12226","article-title":"Exposure to antiepileptic drugs in utero and child development: a prospective population-based study","volume":"54","author":"Veiby","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.encep.2024.03.001_bib0075","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jnnp-2020-323028","article-title":"Paternal exposure to antiepileptic drugs and offspring outcomes: a nationwide population-based cohort study in Sweden","volume":"91","author":"Tomson","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.encep.2024.03.001_bib0080","unstructured":"Epilim\u00ae (Valproate) - Risk of neurodevelopmental disorders including autism spectrum disorders in children after paternal exposure. HSA 2023. https:\/\/www.hsa.gov.sg\/announcements\/dear-healthcare-professional-letter\/epilim-(valproate)---risk-of-neurodevelopmental-disorders-including-autism-spectrum-disorders-in-children-after-paternal-exposure. (accessed August 5, 2023)."}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700624000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700624000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T15:48:12Z","timestamp":1723132092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700624000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0013700624000666"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2024.03.001","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The French National Agency for the Safety of Medicines and Health Products (ANSM) warns doctors about the risks of prescribing valproate to men of reproductive age","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}